Class IITerminatedD-1520-2016
Drug recall · October 5, 2016
Sennazon recall
Why: CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.
- Lots / codes
Lot #: 20391519, Exp 11/17
- Quantity
- 1,008 bottles
- Company
- Pharmatech LLC, Davie, FL
- Distribution
- Nationwide
- Initiated
- August 8, 2016 · Voluntary: Firm initiated
- Classified
- September 27, 2016
- Reported
- October 5, 2016
- Ended
- September 23, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedOct 5, 2016NinjacofPharmatech LLC · D-1521-2016Class IITerminatedOct 5, 2016Ninjacof-APharmatech LLC · D-1522-2016Class IITerminatedOct 5, 2016Aller-ChlorPharmatech LLC · D-1523-2016Class IITerminatedOct 5, 2016Diocto SyrupPharmatech LLC · D-1524-2016Class IITerminatedOct 5, 2016Senexon LiquidPharmatech LLC · D-1525-2016Class IITerminatedOct 5, 2016Senna SyrupPharmatech LLC · D-1526-2016
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.